Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge

Astrid Eliasen; Michael Thude Callesen; Kim Peder Dalhoff; Catherine Rechnitzer; Kjeld Schmiegelow; Henrik Schrøder; Ruta Tuckuviene; Helle Holst

Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge

Translated title of the contribution: Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents

Astrid Eliasen, Michael Thude Callesen, Kim Peder Dalhoff, Catherine Rechnitzer, Kjeld Schmiegelow, Henrik Schrøder, Ruta Tuckuviene, Helle Holst

Abstract

Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.

Translated title of the contribution	Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents
Original language	Danish
Article number	V11170851
Journal	Ugeskrift for Laeger
Volume	180
Issue number	35
Number of pages	7
ISSN	0041-5782
Publication status	Published - 2018

Access to Document

http://ugeskriftet.dk/videnskab/manglende-evidens-i-forebyggelse-af-kemoterapiinduceret-kvalme-og-opkastning-hos-boern-og

Cite this

Eliasen, A., Callesen, M. T., Dalhoff, K. P., Rechnitzer, C., Schmiegelow, K., Schrøder, H., Tuckuviene, R., & Holst, H. (2018). Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge. Ugeskrift for Laeger, 180(35), [V11170851]. http://ugeskriftet.dk/videnskab/manglende-evidens-i-forebyggelse-af-kemoterapiinduceret-kvalme-og-opkastning-hos-boern-og

Eliasen, A, Callesen, MT, Dalhoff, KP, Rechnitzer, C, Schmiegelow, K, Schrøder, H, Tuckuviene, R & Holst, H 2018, 'Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge', Ugeskrift for Laeger, vol. 180, no. 35, V11170851. <http://ugeskriftet.dk/videnskab/manglende-evidens-i-forebyggelse-af-kemoterapiinduceret-kvalme-og-opkastning-hos-boern-og>

@article{c18abbf6086f43b994b826fa22da280c,

title = "Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos b{\o}rn og unge",

abstract = "Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.",

author = "Astrid Eliasen and Callesen, {Michael Thude} and Dalhoff, {Kim Peder} and Catherine Rechnitzer and Kjeld Schmiegelow and Henrik Schr{\o}der and Ruta Tuckuviene and Helle Holst",

year = "2018",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "35",

}

TY - JOUR

T1 - Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge

AU - Eliasen, Astrid

AU - Callesen, Michael Thude

AU - Dalhoff, Kim Peder

AU - Rechnitzer, Catherine

AU - Schmiegelow, Kjeld

AU - Schrøder, Henrik

AU - Tuckuviene, Ruta

AU - Holst, Helle

PY - 2018

Y1 - 2018

N2 - Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.

AB - Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.

M3 - Tidsskriftartikel

C2 - 30152323

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 35

M1 - V11170851

ER -

Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge

Abstract

Access to Document

Fingerprint

Cite this